A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

NCT06145893 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Behçet's Disease

Interventions

DRUG: Hemay005
DRUG: Hemay005
DRUG: Placebo

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd